- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Distributors Sell Flagship Product Nano eNabler in Europe and Japan
BioForce Nanosciences Holdings, Inc. (OTC BB: BFNH), a producer of integrated biological and mechanical systems for life science researchers at the micro and nano scales, today announced that its overseas distributors' sales success helped the Company set a new sales record of its flagship product, the Nano eNabler™, in the fourth quarter of 2007.
The Nano eNabler is being used by customers for a variety of research activities, with two key areas being cell biology and biosensor development. The Nano eNabler's ability to deposit miniscule quantities of biological materials reproducibly and with extremely high precision allows researchers to create novel experimental systems and tests in areas such as cancer diagnostics and treatment and rapid detection of biological agents.
Overseas distributors accounted for 4 of the of 5 Nano eNablers BioForce sold in the fourth quarter of 2007, for a total of 11 sold to research entities around the world since inception in 2006. In addition, it has placed 20 units in research institutes, 18 of which are in North America, for a 12-month free trial period, and these have already begun to convert to sales, accounting for 2 of the 11 sold. Management believes that most will convert to sales by the end of 2008.
The BioForce distributors operate outside the US, which is already serviced by the BioForce in-house sales team. By building a network of global distributors, the management of BioForce believes it can meet the needs of the global life sciences market without the overheads required by establishing its own sales team on every continent. In 2008, the Company intends to increase the number of distributors with whom it works to expand its geographical coverage.
Kerry Frey, BioForce's President and Chief Operating Officer, said, "We are extremely pleased with the performance of our distribution network overseas. It takes a dedicated effort to sell a specialized product like the Nano eNabler system, but our highly trained distributors have proven up to that task. Additionally, we have done demonstrations in various countries, most recently in Thailand, so that our distributors can show potential clients the Nano eNabler in action. This caters to the scientific community's desire to have hands-on experience of a device before committing research funds toward a purchase."
Frey continued, "In the UK, we work with Windsor Scientific, and they sold a Nano eNabler to the Department of Chemistry at the University of Wales in Bangor, Wales. Earlier in the year, Windsor sold another unit to the University of Limerick in Ireland.
"On the Continent, we are fortunate to be working with NanoAndMore GmbH, which sold a unit in Spain to CEEI in Barcelona, and another in Germany to the European Molecular Biology Laboratory (EMBL) in Heidelberg. In Japan, Meiwafosis is our distributor, and they sold a unit to an influential national research institute in that country.
Frey concluded, "This overseas distribution network is a vital component of our platform for sales growth that will complement our American in-house operation effectively. They have proved (proven?) that the product is in demand around the world and that they can successfully sell it. We now have distributors in not only the UK, Germany and Japan but also in China, Australia, South Korea, Malaysia, Singapore, Thailand, India, Indonesia, Taiwan and Vietnam. As 2008 progresses, we expect to add further distributors in Canada and Latin America, and we expect our sales to increase significantly over 2007's results."
About BioForce Nanosciences Holdings, Inc.
BioForce Nanosciences creates products and solutions for the life sciences by integrating biological and mechanical systems at the micro and nano scales. BioForce’s flagship product, the Nano eNabler™ molecular printer, gives the Company and its customers a platform for development and discovery by printing tiny domains of biological materials on surfaces with nanometer special precision. BioForce technology is being used in areas such as biosensor functionalization; pattering and cell adhesion; and the printing of proteins to guide neural cell growth. For more information, visit www.bioforcenano.com or call 515-233-8333.
This news release contains forward-looking information that may be affected by certain risks and uncertainties, including those risks and uncertainties described in BioForce Nanosciences' most recent filings with the Securities and Exchange Commission. BioForce Nanosciences' actual results could differ materially from such forward-looking statements. BioForce assumes no duty to update these statements at any future date.
For more information, please click here
BioForce Nanosciences Holdings, Inc.
Gregory D. Brown, 515-233-8333 ext# 118
Chief Financial Officer
Porter, Levay & Rose
Marlon Nurse, VP – Investor Relations
Jeffrey Myhre, VP – Editorial
Copyright © Business Wire 2008If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Graphenea celebrates fifth anniversary April 27th, 2015
ORNL reports method that takes quantum sensing to new level April 23rd, 2015
Richards-Kortum elected to American Academy of Arts and Sciences: April 22nd, 2015
Arrowhead to Report Fiscal 2015 First Quarter Financial Results February 2nd, 2015
Graphenea sales more than double in 2014 January 29th, 2015
New class of 3D-printed aerogels improve energy storage April 22nd, 2015
Printing Silicon on Paper, with Lasers April 21st, 2015